These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15306638)

  • 1. Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.
    Xie T; Tong L; McCann UD; Yuan J; Becker KG; Mechan AO; Cheadle C; Donovan DM; Ricaurte GA
    J Neurosci; 2004 Aug; 24(32):7043-50. PubMed ID: 15306638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.
    Xie T; Tong L; Barrett T; Yuan J; Hatzidimitriou G; McCann UD; Becker KG; Donovan DM; Ricaurte GA
    J Neurosci; 2002 Jan; 22(1):274-83. PubMed ID: 11756511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells.
    Ajjimaporn A; Swinscoe J; Shavali S; Govitrapong P; Ebadi M
    Brain Res Bull; 2005 Nov; 67(6):466-75. PubMed ID: 16216695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity.
    Miyazaki I; Asanuma M; Kikkawa Y; Takeshima M; Murakami S; Miyoshi K; Sogawa N; Kita T
    Glia; 2011 Mar; 59(3):435-51. PubMed ID: 21264950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
    Chipana C; Camarasa J; Pubill D; Escubedo E
    Neuropharmacology; 2006 Sep; 51(4):885-95. PubMed ID: 16901518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia.
    Trendelenburg G; Prass K; Priller J; Kapinya K; Polley A; Muselmann C; Ruscher K; Kannbley U; Schmitt AO; Castell S; Wiegand F; Meisel A; Rosenthal A; Dirnagl U
    J Neurosci; 2002 Jul; 22(14):5879-88. PubMed ID: 12122050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
    Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T
    Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the metallothionein gene in liver and brain of mice and rats.
    Choudhuri S; McKim JM; Klaassen CD
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):1-10. PubMed ID: 8470112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
    Itzhak Y; Anderson KL; Ali SF
    Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
    Federici M; Sebastianelli L; Natoli S; Bernardi G; Mercuri NB
    Biol Psychiatry; 2007 Sep; 62(6):680-6. PubMed ID: 17511969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
    Nash JF; Yamamoto BK
    Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
    Miller DB; O'Callaghan JP
    Ann N Y Acad Sci; 1993 May; 679():321-4. PubMed ID: 8099774
    [No Abstract]   [Full Text] [Related]  

  • 17. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK; Ebadi M
    Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g).
    Sogawa CA; Miyazaki I; Sogawa N; Asanuma M; Ogawa N; Furuta H
    Brain Res; 2000 Jan; 853(2):310-6. PubMed ID: 10640628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
    Rizzo FR; Federici M; Mercuri NB
    Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.